Stefania Jabłońska
 |
Stefania Jabłońska (born 7 September 1920 – 8 May 2017) was a renowned Polish dermatologist, best known for her pioneering research in the field of dermatology, particularly in the study of skin cancer and human papillomavirus (HPV). Her work significantly advanced the understanding of the relationship between HPV and skin cancer.
Early Life and Education[edit | edit source]
Stefania Jabłońska was born in Warsaw, Poland. She pursued her medical education at the University of Warsaw, where she developed a keen interest in dermatology. Her early academic career was marked by a dedication to understanding the complexities of skin diseases.
Career[edit | edit source]
Jabłońska's career in dermatology began in earnest after World War II. She worked at the Medical University of Warsaw, where she eventually became a professor and head of the Department of Dermatology. Her research focused on the pathogenesis of skin diseases, with a particular emphasis on viral infections and their role in skin cancer.
Research on HPV and Skin Cancer[edit | edit source]
Jabłońska was one of the first researchers to identify the link between human papillomavirus (HPV) and certain types of skin cancer. Her studies demonstrated that HPV was not only a cause of cervical cancer but also played a significant role in the development of squamous cell carcinoma of the skin. This groundbreaking work laid the foundation for further research into the prevention and treatment of HPV-related cancers.
Awards and Honors[edit | edit source]
Throughout her career, Jabłońska received numerous awards and honors for her contributions to medical science. She was a recipient of the Ordre national du Mérite and the Order of Polonia Restituta.
Legacy[edit | edit source]
Stefania Jabłońska's work has had a lasting impact on the field of dermatology. Her research not only advanced the understanding of HPV and its role in skin cancer but also influenced public health policies regarding the prevention and treatment of viral infections. Her legacy continues to inspire dermatologists and researchers worldwide.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
